Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026)

Zai Lab (ZLAB) posted quarterly Change in Accured Expenses of -$17.6 million for Q1 2026, up 24.22% year-on-year from -$14.2 million in Q1 2025, and down 253.12% on a QoQ basis from $11.5 million in Q4 2025.

Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Change in Accured Expenses for 7 consecutive years, with -$17.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Accured Expenses rose 24.22% year-over-year to -$17.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 193.64% YoY) and the FY2025 annual result came in at $4.8 million, up 121.57% from the prior year.
  • Change in Accured Expenses fell to -$17.6 million in Q1 2026 per ZLAB's latest filing, from $11.5 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for ZLAB reached as high as $19.6 million in Q4 2023 and fell as low as -$34.2 million in Q1 2024.
  • A 5-year average of -$453411.8 and a median of $5.7 million in 2022 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 140.71% — and 2025, when it jumped 836.09%.
  • Year by year, Change in Accured Expenses stood at $5.8 million in 2022, then jumped by 239.75% to $19.6 million in 2023, then decreased by 24.26% to $14.8 million in 2024, then retreated by 22.34% to $11.5 million in 2025, then tumbled by 253.12% to -$17.6 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$17.6 million, $11.5 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - 1.13 Mn
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - 931,000.00
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.79 Bn 62.79 Bn - -
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn -176.03 Mn
10 Zai Lab 20.76 Bn 20.01 Bn 61.30 Mn -17.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.64 Mn
Mar 31, 2026 -17.64 Mn
Dec 31, 2025 11.52 Mn
Dec 31, 2025 11.52 Mn
Sep 30, 2025 9.18 Mn
Sep 30, 2025 9.18 Mn
Jun 30, 2025 7.33 Mn
Jun 30, 2025 7.33 Mn
Mar 31, 2025 -23.28 Mn
Mar 31, 2025 -23.28 Mn
Dec 31, 2024 14.83 Mn
Dec 31, 2024 14.83 Mn
Sep 30, 2024 -1.25 Mn
Sep 30, 2024 -1.25 Mn
Jun 30, 2024 -1.40 Mn
Jun 30, 2024 -1.40 Mn
Mar 31, 2024 -34.20 Mn
Mar 31, 2024 -34.20 Mn
Dec 31, 2023 19.58 Mn
Dec 31, 2023 19.58 Mn